Intestinal stem cell responses to ischemic injury in a large animal model
大型动物模型中肠道干细胞对缺血性损伤的反应
基本信息
- 批准号:8967819
- 负责人:
- 金额:$ 12.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAbdominal PainAddressAffectAnimal ModelApoptosisBiological AssayBiological MarkersBiological PreservationBlood VesselsCell Culture SystemCell CycleCell DeathCell HypoxiaCell LineCell SurvivalCellsCessation of lifeChronicClinicalClinical MedicineColumnar CellCultured CellsDataDevelopmentDiarrheaDiseaseEmergency SituationEnvironmentEpithelialEpithelial CellsEpitheliumExcisionExperimental ModelsFamily suidaeGoalsHIF1A geneHemorrhagic ShockHemostatic functionHistologicHomeostasisHumanHypoxiaHypoxia-Inducible Factor PathwayIn VitroInjuryIntestinal VolvulusIntestinesIschemiaIschemic Bowel DiseaseLiteratureMalnutritionMediatingMediator of activation proteinMesenteric Vascular OcclusionMessenger RNAModelingMolecularMolecular BiologyNatural regenerationNecrotizing EnterocolitisNeonatalOperative Surgical ProceduresOutcomeOxygenPathway interactionsPatientsPhasePopulationPositioning AttributeProteinsPulmonary Heart DiseaseQuality of lifeRecoveryRegenerative responseResearchResistanceRiskRodentRoleScientistSepsisShort Bowel SyndromeSignal Transduction PathwayStem Cell ResearchStem cellsStructure of intestinal glandSystemTestingTimeTrainingTranslationsVillusWitWorkascorbatebasebeta catenincareer developmentcaspase-3clinically relevantcrypt celldefined contributionfunctional outcomesimprovedin vivoinjuredlentiviral-mediatedmortalitynew therapeutic targetnovelpublic health relevancerepairedresponseself-renewalskillsstemstem cell biologystem cell populationtherapeutic targettranslational approach
项目摘要
DESCRIPTION (provided by applicant): Intestinal mucosal epithelial injury compromises barrier function and can cause sepsis and death. Ischemia and the resulting hypoxia contribute significantly to epithelial damage in diseases such as neonatal necrotizing enterocolitis, volvulus, cardiopulmonary disease and hemorrhagic shock. Intestinal epithelial stem cells (IESCs) offer a promising therapeutic target due to their capacity to regenerate the mucosal epithelial barrier. Current evidence supports the existence of two IESC populations: a) Crypt Base Columnar (CBC) cells (Lgr5 enriched); and b) reserve or more quiescent stem cells (QSC; concentrated at the +4 position; Hopx enriched; slower cycling). Understanding their contribution to epithelial repair is critical to optimal therapeutic targeting. The hypoxia inducibe factor (HIF) pathway regulates cell survival, proliferation and differentiation in environments wit decreased oxygen. The HIF pathway activates the Wnt-/ß-catenin pathway which is known to be critical to IESC survival, proliferation and intestinal epithelial hemostasis. We propose that a
porcine model of ischemia will aid in the translation and ultimate application of IESC research to clinical medicine. This proposal will investigate the hypothesis that distinct IESC populations wil show differing resistance to ischemic injury and that HIF pathway activation in IESCs mediates this resistance and/or IESC-mediated regeneration of severely injured epithelium after ischemia. Two specific aims will address this hypothesis by assessing: (1) if IESC cells expressing biomarkers of CBCs or QSCs show differential resistance to ischemic injury and different contributions to the subsequent repair and regenerative response; and (2) the role of the HIF pathway within the IESC populations during ischemia and subsequent regeneration. To accomplish specific aim 1, an in vivo porcine mesenteric vascular occlusion model will create increasing degrees of ischemic injury. Biomarkers of CBCs and QSCs will be used in quantitative histologic, protein and mRNA analyses to confirm preliminary data for ischemia-induced loss of CBCs but preservation of QSCs. Co-localization of the specific biomarkers of the two IESCs with expression of apoptosis markers will assess the impact of ischemia on IESC death. The time course of QSC versus CBC proliferation during ischemia and repair with be assessed using co- localization with EdU, PCNA and Phosphohistone 3B. The time course of HIF pathway activation after ischemia and during repair will be defined by assays of mediators of protein and mRNA levels. Crypt and cell culture systems will be utilized in specific aim 2 to manipulate and define the functional role of the HIF pathway in response to hypoxia. The successful outcome of this project will define the impact of ischemia on IESCs and potentially new therapeutic targets to improve epithelial repair as well as provide additional expertise in cel and molecular biology focused specifically on IESC and hypoxia-related pathways. These training and career development activities will promote a successful transition to independence as an academic research scientist.
描述(由适用提供):肠粘膜上皮损伤损害了障碍功能,并可能导致败血症和死亡。缺血和由此产生的缺氧对诸如新生儿坏死性小肠结肠炎,沃尔图鲁斯,心肺疾病和出血性休克等疾病的上皮损害显着促进。肠上皮干细胞(IESC)由于能力再生粘膜上皮屏障而提供了有前途的治疗靶标。当前的证据支持两个IESC种群的存在:a)加密基柱(CBC)细胞(LGR5富集); b)储备或更多静止的干细胞(QSC;集中在+4位置;富含Hopx;较慢的骑行)。了解它们对上皮修复的贡献对于最佳治疗靶向至关重要。缺氧诱导因子(HIF)途径调节环境中的细胞存活,增殖和分化降低氧气。 HIF途径激活Wnt-/ß-catenin途径,该途径对IESC存活,增殖和肠上皮止血至关重要。我们建议
缺血的猪模型将有助于将IESC研究的翻译和最终应用于临床医学。该提议将调查以下假设:不同的IESC种群将显示出对缺血性损伤的不同耐药性,而IESCS中的HIF途径激活了这种耐药性和/或IESC介导的缺血上皮细胞的再生。通过评估:(1)表达CBCS或QSC的IESC细胞表现出对缺血性损伤的不同耐药性以及对随后的修复和再生反应的不同贡献,将解决这一假设的两个具体目标:(1) (2)在缺血和随后再生期间,HIF途径在IESC种群中的作用。为了完成特定的目标1,体内猪肠系膜血管闭塞模型将造成越来越多的缺血性损伤。 CBC和QSC的生物标志物将用于定量的组织学,蛋白质和mRNA分析,以确认缺血诱导的CBC丢失但保留QSC的初步数据。两种IESC的特定生物标志物与凋亡标志物表达的共定位将评估缺血对IESC死亡的影响。缺血期间QSC与CBC增殖的时间过程,并使用与EDU,PCNA和磷酸组织3B共定位进行评估。缺血后和修复过程中HIF途径激活的时间过程将由蛋白质和mRNA水平的介体的主张来定义。地穴和细胞培养系统将用于特定目标2中,以操纵和定义HIF途径对缺氧的功能作用。该项目的成功结果将定义缺血对IESC和潜在的新治疗靶标的影响,以改善上皮修复,并在CEL和分子生物学方面提供更多专门针对IESC和缺氧相关途径的专业知识。这些培训和职业发展活动将促进作为学术研究科学家的成功过渡到独立性的过渡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liara M Gonzalez其他文献
Liara M Gonzalez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
肠易激综合征(IBS)腹痛的细胞和分子机制研究
- 批准号:81971046
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
中枢介导的腹痛综合征患者大脑多模态磁共振成像研究
- 批准号:81800482
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
疏肝健脾法通过调控组蛋白乙酰化修饰降低肝郁脾虚IBS-D内脏高敏感的机制研究
- 批准号:81703955
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于PKCγ/ERK1/2/MAPK信号通路探讨安肠汤缓解腹泻型肠易激综合征腹痛研究
- 批准号:81560754
- 批准年份:2015
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
针刺治疗功能性消化不良上腹痛综合征的疼痛记忆淡化机制研究
- 批准号:81473602
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
相似海外基金
MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
- 批准号:
10836298 - 财政年份:2023
- 资助金额:
$ 12.16万 - 项目类别:
Unlocking the Economics of Cancer Control in Uganda Using KeyScope
使用 KeyScope 解锁乌干达癌症控制的经济学
- 批准号:
10851065 - 财政年份:2023
- 资助金额:
$ 12.16万 - 项目类别:
The First Non-Surgical Anti-Stomal Prolapse Medical Device to Treat and Prevent Stomal Prolapse
第一个治疗和预防造口脱垂的非手术防造口脱垂医疗器械
- 批准号:
10482616 - 财政年份:2022
- 资助金额:
$ 12.16万 - 项目类别: